<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Intellia is soaring after promising trial results using CRISPR technology. Alethia Young, Cantor Fitzgerald senior biotech analyst, joins ‘Closing Bell’ to discuss the significance of the trial and what it could mean for the industry.
...read full article on CNBC Television
